Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care, III. Adult advanced cardiac life support. JAMA1992;268:2199–2241.
2.
ACC/AHA Task Force Report. Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). J Am Coll Cardiol1990;16:249–292.
3.
HoffmanBB, LefkowitzRJ. Catecholamines and sympathomimetic drugs. In: GilmanAG, RallTW, NiesAS, TaylorP, editors. Goodman and Gilman's the pharmacological basis of therapeutics, 8/e. New York: Pergamon Press, 1990. Chapter 10:187–220.
4.
StitzelRE, RobinsonRL. Adrenomimetic drugs. In: CraigCR, StitzelRE, editors. Modern pharmacology, 3rd ed. Boston: Little, Brown and Co., 1990. Chapter 11:136–154.
5.
OpieLH. Receptors and signal transduction. In: The heart: physiology and metabolism, 2nd ed. New York: Raven Press, 1991:147–175.
6.
MilnorWR. Properties of cardiac cells. In: Cardiovascular physiology. New York: Oxford Press, 1990:62–110.
7.
KitakazeM, HoriM, TamaiJ, IwakuraK, KoretsuneY, KagiyaT, IwaiK, KitabatakeA, InoueM, KamadaT.α2-adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs. Circ Res1987;60:631–639.
8.
BeckCS, RandHJ. Cardiac arrest during anesthesia and surgery. JAMA1949;141:1230–1233.
9.
ReddingJS, PearsonJW. Resuscitation from asphyxia. JAMA1962;182:283–286.
10.
OttoCW, YakaitisRW. The role of epinephrine in CPR: A reappraisal. Ann Emerg Med1984;13:840–843.
11.
ParadisNA, MartinGB, RiversEP, GoettingMG, AppletonTJ, FeingoldM, NowakRM. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA1990;263:1106–1113.
12.
SandersAB, EwyGA, TaftTV. Prognostic and therapeutic importance of the aortic diastolic pressure in resuscitation from cardiac arrest. Crit Care Med1984;12:871–873.
13.
DowneyJM, ChagrasulisRW, HemphillV.Quantitative study of intramyocardial compression in the fibrillating heart. Am J Physiol1979;237:H191–H196.
14.
NiemannJT. Differences in cerebral and myocardial perfusion during closed-chest resuscitation. Ann Emerg Med1984;13:849–853.
15.
MichaelJR, GuerciAD, KoehlerRC, ShiA, TsitlikJ, ChandraN, NiedermeyerE, RogersMC, TraystmanRJ, WeisfeldtML. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation1984;69:822–835.
16.
SchleienCL, DeanJM, KoehlerRC, MichaelJR, ChantarojanasiriT, TraystmanR, RogersMC. Effect of epinephrine on cerebral and myocardial perfusion in an infant animal preparation of cardiopulmonary resuscitation. Circulation1986;73:809–817.
17.
ZollPM. Rational use of drugs for cardiac arrest and after cardiac resuscitation. Am J Cardiol1971;27:645–649.
18.
GoldbergAH. Current concepts: cardiopulmonary arrest. N Engl J Med1974;290:381–385.
19.
YakaitisRW, OttoCW, BlittCD. Relative importance of and adrenergic receptors during resuscitation. Crit Care Med1979; 7:293–296.
20.
OttoCW, YakaitisRW, BlittCD. Mechanism of action of epinephrine in resuscitation from asphyxial arrest. Crit Care Med1981;9:321–324.
21.
OttoCW, YakaitisRW, ReddingJS, BlittCD. Comparison of dopamine, dobutamine, and epinephrine in CPR. Crit Care Med1981;9:640–643.
22.
YakaitisRW, EwyGA, OttoCW, TarenDL, MoonTE. Influence of time and therapy on ventricular defibrillation in dogs. Crit Care Med1980;8:157–163.
23.
DitcheyRV, LindenfeldJ.Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation1988;78:382–389.
24.
NeillWA, PhelpsNC, OxendineJM, MahlerDJ, SumDN. Effect of heart rate on coronary blood flow distribution in dogs. Am J Cardiol1973;32:306–312.
25.
OpieLH. Oxygen supply: Coronary flow. In: The heart. Physiology and metabolism, 2nd ed. New York: Raven Press, 1991:277–300.
BrownCG, WermanHA, DavisEA, KatzS, HamlinRL. The effect of high-dose phenylephrine versus epinephrine on regional cerebral blood flow during CPR. Ann Emerg Med1987;743–748.
28.
ParadisNA, KoscoveEM. Epinephrine in cardiac arrest: A critical review. Ann Emerg Med1990;19:1288–1301.
29.
TurnerLM, ParsonsM, LuetkemeyerRC, RuthmanJC, AndersonRJ, AldagJC. A comparison of epinephrine and methoxamine for resuscitation from electromechanical dissociation in human beings. Ann Emerg Med1988;17:443–449.
30.
OlsonDW, ThakurR, StuevenHA, ThompsonB, GruchowH, HendleyGE, HargartenKM, AprahamianC.Randomized study of epinephrine versus methoxamine in prehospital ventricular fibrillation. Ann Emerg Med1989;18:250–253.
31.
RalstonSH, VoorheesWD, BabbsCF. Intrapulmonary epinephrine during cardiopulmonary resuscitation in dogs. Ann Emerg Med1984;13:79–86.
32.
ReddingJS, PearsonJW. Resuscitation from ventricular fibrillation. JAMA1968;203:255–260.
33.
RalstonSH. Alpha agonist drug usage during CPR. Ann Emerg Med1984;13:786–789.
34.
TangW, WeilMH, SunS, GazmuriRJ, DuggalC, BiseraJ, RackowEC. Epinephrine produces both hypoxemia and hypercarbia during CPR (abstract). Crit Care Med1990;18:S276.
35.
CrileG, DolleyDT. Experimental research into resuscitation of dogs killed by anesthetics and asphyxia. J Exp Med1906;8:713–720.
36.
CallahamM.Epinephrine doses in cardiac arrest: Is it time to outgrow the orthodoxy of ACLS (editorial)?Ann Emerg Med1989;18:1011–1012.
37.
KoscoveEM, ParadisNA. Successful resuscitation from cardiac arrest using high-dose epinephrine therapy: Report of two cases. JAMA1988;259:3031–3034.
38.
BrownCG, WermanHA, DavisEA, HamlinR, HobsonJ, AshtonJA. Comparative effect of graded doses of epinephrine on regional brain blood flow during CPR in a swine model. Ann Emerg Med1986;15:1138–1144.
39.
BrownCG, WermanHA, DavisEA, HobsonJ, HamlinRL. The effects of graded doses of epinephrine on regional myocardial blood flow during cardiopulmonary resuscitation in swine. Circulation1987;75:491–497.
40.
BrownCG, TaylorRB, WermanHA, LuuT, SpittlerG, HamlinRL. Effect of standard doses of epinephrine on myocardial oxygen delivery and utilization during cardiopulmonary resuscitation. Crit Care Med1988;16:536–539.
41.
LindnerKH, AhnefeldFW, BowdlerIM. Comparison of different doses of epinephrine on myocardial perfusion and resuscitation success during cardiopulmonary resuscitation in a pig model. Am J Emerg Med1991;9:27–31.
42.
LindnerKH, AhnefeldFW, PrengelAW. Comparison of standard and high-dose adrenaline in the resuscitation of aystole and electromechanical dissociation. Acta Anaesthesiol Scand1991;35:253–256.
43.
StiellIG, HebertPC, WeitzmanBN, WellsGA, RamanS, StarkRM, HigginsonLAJ, AhujaJ, DickinsonG.A study of high-dose epinephrine in human CPR (abstract). Ann Emerg Med1992;21:606.
44.
CallahamM, MadsenCD, BartonCW, SaundersCE, DaleyM, PointerJ.A randomized clinical trial of high-dose epinephrine and norepinephrine versus standard-dose epinephrine in prehospital cardiac arrest (abstract). Ann Emerg Med1992;21:606–607.
45.
ParadisNA, RiversEP, MartinGB, SmithlineHA, GoettingMG, AppletonTJ, WortsmanJ, NowakRM. The change in arterial epinephrine levels after standard and high dose epinephrine during CPR in humans (abstract). Crit Care Med1990;18:S221.
46.
CollinsworthKA, KalmanSM, HarrisonDC. The clinical pharmacology of lidocaine as an antiarrhythmic drug. Circulation1974;50:1217–1230.
LucchesiBR. Pharmacology of antiarrhythmic drugs. In: CraigCR, StitzelRE, ed. Modern Pharmacology. Chapter 25:333–369.
49.
GadsbyDC, WitAL. Electrophysiologic characteristics of cardiac cells and the genesis of cardiac arrhythmias. In: WilkersonRD, ed. Cardiac pharmacology. New York: Academic Press, 1981:229–274.
50.
SinghBN, OpieLH, MarcusFI. Antiarrhythmic agents. In: OpieLH, ed. Drugs for the heart, 3rd ed. Philadelphia: WB Saunders Co, 1991:180–216.
51.
DavisonR, ParkerM, AtkinsonAJ. Excessive serum lidocaine levels during maintenance infusions: Mechanisms and prevention. Am Heart J1982;104:203–208.
52.
KosterRW, DunningAJ. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med1985;313:1105–1110.
53.
LieKI, WellensHJ, van CapelleFJ, DurrerD.Lidocaine in the prevention of primary ventricular fibrillation. N Engl J Med1974;291:1324–1326.
54.
DeSilvaRA, HennekensCH, LownB, CasscellsW.Lignocaine prophylaxis in acute myocardial infarction: An evaluation of randomised trials. Lancet1981;2:855–858.
55.
CarruthJE, SilvermanME. Ventricular fibrillation complicating acute myocardial infarction: Reasons against the routine use of lidocaine. Am Heart J1982;104:545–550.
56.
DunnHM, McCombJM, KinneyCD, CampbellNPS, ShanksRG, MacKenzieG, AdgeyAAJ. Prophylactic lidocaine in the early phase of suspected myocardial infarction. Am Heart J1985;110:353–362.
57.
MacMahonS, CollinsR, PetoR, KosterRW, YusufS.Effects of prophylactic lidocaine in suspected acute myocardial infarction. JAMA1988;260:1910–1916.
58.
Koch-WeserJ.Drug therapy. Bretylium. N Engl J Med1979; 300:473–477.
59.
EulerDE, ScanlonPJ. Mechanism of the effect of bretylium on the ventricular fibrillation threshold in dogs. Am J Cardiol1985; 55:1396–1401.
60.
CardinalR, SasyniukBI. Electrophysiologic effects of bretylium tosylate on subendocardial Purkinje fibers from infarcted canine hearts. J Pharmacol Exp Ther1978;204:159–174.
61.
HaynesRE, ChinnTL, CopassMK, CobbLA. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: A randomized trial. Am J Cardiol1981; 48:353–356.
62.
OlsonDW, ThompsonBM, DarinJC, MilbrathMH. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med1984;13:807–810.
63.
KooCC, AllenJD, PantridgeJF. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study. Cardiovasc Res1984;18:762–767.
64.
HooverDB. Muscarinic blocking drugs. In: CraigCR, StitzelRE, ed. Modern pharmacology, 3rd ed. Boston: Little, Brown and Co, 1990:178–187.
65.
DauchotP, GravensteinJS. Bradycardia after myocardial ischemia and its treatment with atropine. Anesthesiology1976; 44:501–518.
66.
ScheinmanMM, ThorburnD, AbbottJA. Use of atropine in patients with acute myocardial infarction and sinus bradycardia. Circulation1975;52:627–633.
67.
ChamberlainDA, TurnerP, SneddonJM. Effects of atropine on heart-rate in healthy man. Lancet1967;2:12–15.
68.
KottmeierCA, GravensteinJS. The parasympathomimetic activity of atropine and atropine methylbromide. Anesthesiology1968; 29:1125–1133.
69.
HayesAHJr, CopelanHW, KetchumJS. Effects of large intramuscular doses of atropine on cardiac rhythm. Clin Pharmacol Ther1971;12:482–486.
70.
CoonGA, ClintonJE, RuizE.Use of atropine for bradyasystolic prehospital cardiac arrest. Ann Emerg Med1981;10:462–467.
71.
StuevenHA, TonsfeldtDJ, ThompsonBM, WhitcombJ, KastensonE, AprahamianC.Atopine in asystole: Human studies. Ann Emerg Med1984;13:815–817.
72.
KnoebelSB, McHenryPL, PhillipsJF, WidlanskyS.Atropine-induced cardio-acceleration and myocardial blood flow in subjects with and without coronary artery disease. Am J Cardiol1974; 33:327–332.
73.
WeilMH, AfifiAA. Experimental and clinical studies onlactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation1970;41:989–1001.
74.
GerstPH, FlemingWH, MalmJR. Increased susceptibility of the heart to ventricular fibrillation during metabolic acidosis. Circ Res1966;19:63–70.
75.
CingolaniHE, MattiazziAR, BlesaES, GonzalezNC. Contractility in isolated mammalian heart muscle after acid-base changes. Circ Res1970;26:269–278.
76.
CingolaniHE, FaulknerSL, MattiazziAR, BenderHW, GrahamTPJr. Depression of human myocardial contractility with "respiratory" and "metabolic" acidosis. Surgery1975;77:427–432.
77.
WeilMH, GrundlerW, RackowEC, BiseraJ, MillerJM, MichaelsS.Blood gas measurements in human patients during CPR (abstract). Chest1984;86:282.
78.
WeilMH, RackowEC, TrevinoR, GrundlerW, FalkJL, GriffelMI. Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med1986;315:153–156.
79.
WeilMH, TangW, NocM.Acid-base balance during cardiopulmonary resuscitation. Crit Care Med1993;21:S323–S325.
80.
AdrogueJH, RashadN, GorinAB, YacoubJ, MadiasNE. Assessing acid-base status in circulatory failure. Differences between arterial and central venous blood. N Engl J Med1989;320:1312–1316.
KetteF, WeilMH, van PlantaM, GazmuriRJ, RackowEC. Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation1990;81:1660–1666.
83.
von PlantaM, WeilMH, GazmuriRJ, BiseraJ, RackowEC. Myocardial acidosis associated with CO2 production during cardiac arrest and resuscitation. Circulation1989;80:684–692.
84.
GrundlerW, WeilMH, MasonobuY, MichaelsS.The paradox of venous acidosis and arterial alkalosis during CPR (abstract). Chest1984;86:282.
85.
FederiukCS, SandersAB, KernKB, NelsonJ, EwyGA. The effect of bicarbonate on resuscitation from cardiac arrest. Ann Emerg Med1991;20:1173–1177.
86.
Van BelleH., Specific metabolically active anti-ischemic agents: adenosine and nucleoside transport inhibitors. In: SinghBN, DzauVJ, VanhouttePM, WoosleyRL, ed. Cardiovascular pharmacology and therapeutics. New York: Churchill Livingstone, 1994:217–235.
87.
LermanBB, BelardinelliL.Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation1991;83:1499–1509.
88.
BertoletBD, HillJA. Adenosine: Diagnostic and therapeutic uses in cardiovascular medicine. Chest1993;104:1860–1871.
89.
ParkerRB, McCollamPL. Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia. Clin Pharm1990; 9:261–271.
90.
DiMarcoJP, SellersTD, BerneRM, WestGA, BelardinelliL.Adenosine: Electrophysioligic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation1983;68:1254–1263.
91.
DiMarcoJP, SellersTD, LermanBB, GreenbergML, BerneRM, BelardinelliL.Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol1985;6:417–425.